| 2024-11-20 | +5.83 % |
|
| 2024-11-19 | +2.37 % |
|
| 2024-11-18 | -1.57 % |
|
| 2024-11-15 | -2.64 % |
|
| 2024-11-13 | +3.34 % |
|
| 2024-11-12 | -0.84 % |
|
| 2024-11-11 | -1.97 % |
|
| 2024-11-06 | +10.71 % |
|
| 2024-11-05 | +1.98 % |
|
| 2024-11-01 | +1.12 % |
|
| 2024-10-31 | -3.19 % |
|
| 2024-10-30 | +3.32 % |
|
| 2024-10-29 | -1.27 % |
|
| 2024-10-28 | +0.14 % |
|
| 2024-10-24 | -0.03 % |
|
| 2024-10-23 | -1.4 % |
|
| 2024-10-22 | +0.67 % |
|
| 2024-10-21 | -2.46 % |
|
| 2024-10-18 | +0.3 % |
|
| 2024-10-17 | +4.21 % |
|
| 2024-10-15 | -3.74 % |
|
| 2024-10-14 | +3.69 % |
|
| 2024-10-11 | +2.64 % |
|
| 2024-10-10 | +2.44 % |
|
| 2024-10-09 | +0.93 % |
|
| 2024-10-08 | +2.92 % |
|
| 2024-10-07 | -1.56 % |
|
| 2024-10-04 | -0.72 % |
|
| 2024-10-03 | -1.91 % |
|
| 2024-10-02 | -11.79 % |
|
| 2024-10-01 | -11.77 % |
- Humana Inc. (NYSE:HUM) experienced a significant decline of 11.77% in its stock value, attributed to a noteworthy rise in short interest and potential concerns among investors regarding the company's future performance and recent trading patterns.
- Humana Inc. (HUM) stock fell by -11.77% due to investor reactions following the disclosure of significant new positions by various firms despite the company reporting strong earnings, hinting at broader market or sentiment pressures rather than company-specific issues.
- Humana (HUM) stock fell by 11.77% last night, likely due to negative market movements and investor sentiment following its earnings report, despite the company exceeding earnings expectations and announcing a dividend.
- Humana (HUM) stock experienced a significant decline of -11.77% following a series of investment reports, despite the company previously reporting strong quarterly earnings. The drop may be attributed to market reactions to the latest analyst ratings, concerns about future growth, or changes in market sentiment towards the healthcare sector.
- Humana Inc. (HUM) stock dropped by 11.77% to a new 52-week low, closing at $300.17, due to market reactions likely spurred by a combination of performance expectations, recent analyst ratings, and broader investor sentiment, despite the company previously beating earnings estimates and reporting revenue growth.
|
| 2024-09-30 | -0.89 % |
|
| 2024-09-27 | +2.09 % |
|
| 2024-09-26 | +0.35 % |
|
| 2024-09-25 | -0.09 % |
|
| 2024-09-24 | -0.17 % |
|
| 2024-09-20 | -0.51 % |
|
| 2024-09-11 | -5.26 % |
|
| 2024-09-09 | -3.94 % |
|
| 2024-09-05 | -1.69 % |
|
| 2024-08-14 | -0.13 % |
|
| 2024-08-13 | +2.45 % |
|
| 2024-08-12 | -0.72 % |
|
| 2024-08-09 | +0.15 % |
|
| 2024-08-07 | -2.73 % |
|
| 2024-08-05 | -2.02 % |
|
| 2024-08-02 | +1.29 % |
|
| 2024-08-01 | -0.73 % |
|
| 2024-07-31 | -10.61 % |
|
| 2024-07-25 | +0.03 % |
|
| 2024-07-24 | +0.11 % |
|
| 2024-07-23 | +0.24 % |
|
| 2024-07-22 | -0.62 % |
|
| 2024-07-18 | -3.3 % |
|
| 2024-07-17 | +1.66 % |
- Summary: Meeder Advisory Services Inc. reduced its holdings in Humana Inc. (HUM) by 12.3% in the 1st quarter, leading to the stock experiencing a 1.66% increase last night, with various other institutional investors also adjusting their stakes in the company, due to positive earnings results announced by Humana on April 24th.
Reason for the increase in the Humana (HUM) stock: The stock price of Humana went up due to positive earnings results reported by the company, which exceeded analysts' expectations, including $7.23 earnings per share (EPS) for the quarter and revenue of $29.61 billion, leading to increased confidence and interest from institutional investors.
- The article discusses a potential class action lawsuit against Humana Inc. (HUM) due to alleged false and misleading statements by the company regarding its business operations, resulting in increased medical costs and decreased adjusted earnings per share. Humana stock went up 1.66% last night, possibly due to factors unrelated to the lawsuit, such as positive earnings reports, market trends, or investor sentiment.
|
| 2024-07-16 | +2.96 % |
|
| 2024-07-15 | +0.52 % |
|
| 2024-07-12 | +0.66 % |
|
| 2024-07-11 | +0.15 % |
|
| 2024-07-10 | +1.56 % |
|
| 2024-07-09 | +0.79 % |
|
| 2024-07-05 | +1.65 % |
|
| 2024-07-03 | -3.19 % |
|
| 2024-07-02 | +0.36 % |
|
| 2024-07-01 | -0.04 % |
|
| 2024-06-28 | +2.94 % |
|
| 2024-06-27 | +0.52 % |
|
| 2024-06-26 | +1.49 % |
|
| 2024-06-25 | -0.63 % |
|
| 2024-06-24 | +0.72 % |
|
| 2024-06-21 | -0.54 % |
|
| 2024-06-20 | +2.25 % |
- The article discusses how a class action lawsuit has been filed against Humana, Inc. (HUM) due to allegations that the company misled investors regarding its business prospects, resulting in a significant drop in the stock price on January 18 and 25, 2024. The recent 2.25% increase in Humana stock price may be due to general market trends, positive news for the company elsewhere, or potential investor optimism.
- The article discusses how various institutional investors have increased their stakes in Humana Inc. (HUM) stock recently, with Los Angeles Capital Management LLC notably acquiring more shares, leading to a positive 2.25% increase in the company's stock value. The stock price goes up due to increased confidence and interest from institutional investors boosted by positive earnings results, good financial performance, and dividend payouts from Humana Inc.
- Last night, Humana Inc. (HUM) stock went up by 2.25%, the article contains information about a class action lawsuit filed on behalf of investors who purchased or acquired Humana stock between July 27, 2022, and January 24, 2024, due to alleged false and misleading statements made by the company regarding its business operations, leading to stock price declines resulting in investor losses.
|
| 2024-06-18 | -1.6 % |
|
| 2024-06-17 | -1.03 % |
|
| 2024-06-14 | +0.23 % |
|
| 2024-06-13 | +1.62 % |
|
| 2024-06-12 | +0.87 % |
- The article discusses the positive impact of Humana (HUM) on Kentucky's economy and community through job creation, financial contributions, and community investments amounting to significant amounts annually. The stock of Humana went up by 0.87% last night, possibly due to its strong economic and community footprint, highlighted by its contributions to GDP, tax revenues, charitable donations, and job creation in the state.
- The article discusses potential claims against Humana Inc. and reminds investors of an upcoming deadline to seek a lead plaintiff role in a securities class action. The reason for the recent increase in the Humana (HUM) stock could be due to investors potentially expressing confidence in the company despite the previous financial setbacks and disclosures, which led to a decline in stock prices earlier.
- The article discusses a class action lawsuit against Humana Inc. (HUM) due to alleged violations of federal securities laws during a specific period, resulting in a decline in the company's stock value, and investors can join the case to seek damages; however, the stock was up by 0.87% last night, possibly due to market dynamics or other factors.
|
| 2024-06-11 | +0.7 % |
|
| 2024-06-10 | -0.7 % |
|
| 2024-06-07 | -1.02 % |
|
| 2024-06-06 | -1.54 % |
|
| 2024-06-05 | +0.04 % |
- The article discusses a class action lawsuit against Humana Inc. (HUM) for potential securities fraud, and despite recent negative news that caused the stock to fall in the past, Humana's stock was up by 0.04% last night, likely due to various factors influencing market dynamics on that particular day.
- The article discusses how Humana (NYSE:HUM) stock has performed well, with a 13% increase over the last month, and delves into its Return on Equity (ROE) as a measure of its financial performance. The stock is currently up by 0.04%, with the company's respectable ROE being a contributing factor, even though its net income growth in the past five years has been flat compared to the industry average. Humana's low three-year median payout ratio of 13% suggests potential for higher growth, and despite the concerns about earnings growth, analysts predict a rise in ROE to 15% in the future.
- The article announces a class action lawsuit against Humana Inc. The stock went up 0.04% last night, but the lawsuit alleges that Humana's officers made misleading statements about the company's business, leading to a decline in the market value of the stock.
|
| 2024-06-04 | -0.91 % |
|
| 2024-06-03 | +1.7 % |
|
| 2024-05-31 | +3.09 % |
|
| 2024-05-29 | -1.12 % |
|
| 2024-05-28 | -0.03 % |
|
| 2024-05-23 | -1.23 % |
|
| 2024-05-22 | +0.27 % |
- The article discusses the rise in Humana (HUM) stock by 0.27% and provides an overview of the stock market performance on May 22, 2024, highlighting the positive movement in key indices and individual stocks, with sectors like FMCG and Realty gaining the most. The stock market showed modest gains with indices like BSE Sensex and NSE Nifty closing in the green despite mixed global cues, and it was noted that Humana (HUM) stock goes up due to a settlement agreement with Lupin Pharmaceuticals, Inc. regarding ongoing litigation for Glumetza, a drug for diabetes treatment.
- The article discusses a settlement agreement involving drugmaker Lupin, Health Care Service Corporation, and Humana Inc regarding the diabetes drug Glumetza, with Lupin agreeing to pay $9 million despite denying the allegations, leading to a 0.27% increase in Humana (HUM) stock because the settlement was reached to avoid the costs and uncertainties associated with ongoing litigation.
|
